{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:40:51Z","timestamp":1791927651618,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Quality of life (QoL), appetite, cachexia, and biomarkers [albumin, hemoglobin (Hb), neutrophils, lymphocytes, platelets, C-reactive protein (CRP), tumor necrosis factor alpha (TNF\u03b1), interleukin 6 (IL-6), interleukin 8 (IL-8), C-X-C motif chemokine ligand 5 (CXCL5) and citrullinated histoneH3 (H3Cit)] were compared for 40 cases with advanced cancer and 40 healthy controls. Baseline differences and significant relationships were explored for biomarkers with QoL, appetite, and cachexia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a prospective case\u2013control, age and sex matched study, the European Organisation for the Research and Treatment of Cancer Quality of Life\u2013C30 questionnaire (EORTC-QLQ-C30) for QoL, the Functional Assessment of Anorexia and Cachexia Therapy assessment (FAACT A\/CS-12) for appetite, and a five-factor cachexia assessment tool for cachexia assessment were performed. Routine hematological measurements and blood chemistry analyses together with ELISA procedures and a Multiplex\u00ae bead array platform, were used for biomarker analysis. Descriptive statistics and regression analyses were undertaken. <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 defined statistical significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Global health status (QL-G), functional scales (QL-FS), and symptom scales (QL-SS) differed for cases and controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). In cases, differences were observed for QL-G (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), QL-FS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), and QL-SS (<jats:italic>p<\/jats:italic>\u2009=\u20090.01) compared to standardized references values. FAACT A\/CS-12 scores differed significantly between cases and controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and 30% of cases scored \u201cpoor\u201d appetites. Cachexia was present in 60% of cases. Albumin, lymphocytes, platelets, Hb, platelet to lymphocyte ratio (PLR), systemic immune-inflammation index (SII), CRP, TNF\u03b1, all at <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01, neutrophil to lymphocyte ratio (NLR) (<jats:italic>p<\/jats:italic>\u2009=\u20090.02), IL-6 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.04), and IL-8 (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) differed significantly between cases and controls. No difference was found for CXCL5 or H3Cit. Albumin NLR, Hb, PLR, SII, TNF\u03b1, IL-8, and CRP showed significant relationships with all aspects of QoL. QL-FS was significantly related to CXCL5 (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), significant relationships with FAACT A\/CS-12 included: NLR (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), Hb (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and PLR (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). NLR, PLR, SII, TNF\u03b1, IL-6, IL-8, and CRP correlated positively to cachexia and albumin while Hb and lymphocyte count correlated negatively to cachexia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CXCL5 and H3Cit were not reliable biomarkers for cancer cachexia, nor significantly related to QoL, appetite or cachexia. Albumin, NLR, Hb, PLR, SII, TNF\u03b1, IL-8, and CRP were reliable indicators of QoL, appetite, and cachexia. Future research should include other novel biomarkers namely growth differentiation factor-15 (GDF-15), fibroblast growth factor 21 (FGF-21), fractakline, interferon gamma (IFN-y), IL-16, macrophage colony stimulating factor (M-CSF), and macrophage procoagulant\u2013inducing factor (MPIF).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-024-08549-5","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T22:01:32Z","timestamp":1715724092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia"],"prefix":"10.1007","volume":"32","author":[{"given":"M.","family":"Lipshitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DG.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HC.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BL.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"issue":"2","key":"8549_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1017\/S002966511500419X","volume":"75","author":"AM Ryan","year":"2016","unstructured":"Ryan AM, Power DG, Daly L, Cushen SJ, N\u00ed Bhuachalla E, Prado CM (2016) Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc 75(2):199\u2013211. https:\/\/doi.org\/10.1017\/S002966511500419X","journal-title":"Proc Nutr Soc"},{"issue":"11","key":"8549_CR2","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1007\/s00520-016-3287-y","volume":"24","author":"D Srdic","year":"2016","unstructured":"Srdic D, Plestina S, Sverko-Peternac A, Nikolac N, Simundic AM, Samarzija M (2016) Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer\u2014chemotherapy toxicity and prognostic value. Support Care Cancer 24(11):4495\u20134502. https:\/\/doi.org\/10.1007\/s00520-016-3287-y","journal-title":"Support Care Cancer"},{"issue":"4","key":"8549_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/CCO.0000000000000517","volume":"31","author":"JM Argil\u00e9s","year":"2019","unstructured":"Argil\u00e9s JM, Busquets S, L\u00f3pez-Soriano FJ (2019) Cancer cachexia, a clinical challenge. Curr Opin Oncol 31(4):286\u2013290. https:\/\/doi.org\/10.1097\/CCO.0000000000000517","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"8549_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0224540","volume":"14","author":"M Abraham","year":"2019","unstructured":"Abraham M, Kordatou Z, Barriuso J, Lamarca A, Weaver JM, Cipriano C, Papaxoinis G, Backen A, Mansoor W (2019) Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer. PLoS ONE 14(11):1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0224540","journal-title":"PLoS ONE"},{"key":"8549_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2019.06.020","volume":"67\u201368","author":"AM Ryan","year":"2019","unstructured":"Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE (2019) Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 67\u201368:1\u201311. https:\/\/doi.org\/10.1016\/j.nut.2019.06.020","journal-title":"Nutrition"},{"issue":"2","key":"8549_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00520-015-2826-2","volume":"24","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Ruijgrok C, Ostelo RW, de Vet HCW, Verheul HMW, van der Schueren MAE, Langius JAE (2016) The assessment of anorexia in patients with cancer: cut-off values for the FAACT\u2013A\/CS and the VAS for appetite. Support Care Cancer 24(2):661\u2013666. https:\/\/doi.org\/10.1007\/s00520-015-2826-2","journal-title":"Support Care Cancer"},{"issue":"10","key":"8549_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1023\/A:1016670403148","volume":"9","author":"JM Ribaudo","year":"2000","unstructured":"Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tcheckmedyian NS, Von Roenn J, Leslier WT et al (2000) Re-validation and shortening of the functional assessment of anorexia\/cachexia therapy (FAACT) questionnaire. Qual Life Res 9(10):1137\u20131146. https:\/\/doi.org\/10.1023\/A:1016670403148","journal-title":"Qual Life Res"},{"issue":"12","key":"8549_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123787","volume":"12","author":"A Narasimhan","year":"2020","unstructured":"Narasimhan A, Shahda S, Kays JK, Perkins SM, Cheng L, Schloss KNH, Schloss D et al (2020) Identification of potential serum protein biomarkers and pathways for pancreatic cancer cachexia using an aptamer-based discovery platform. Cancers 12(12):1\u201323. https:\/\/doi.org\/10.3390\/cancers12123787","journal-title":"Cancers"},{"issue":"5","key":"8549_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jpainsymman.2009.03.012","volume":"38","author":"M Davis","year":"2009","unstructured":"Davis M, Yavuzsen T, Kirkova J, Walsk D, Karafa M, LeGrand S, Lagman R (2009) Validation of a simplified anorexia questionnaire. J Pain Symptom Manage 38(5):691\u2013697. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.03.012","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"8549_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jcsm.12275","volume":"9","author":"T Zhou","year":"2018","unstructured":"Zhou T, Wang B, Liu H, Yang K, Thapa S, Zhang H, Li L, Yu S (2018) Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients. J Cachexia Sarcopenia Muscle 9(2):306\u2013314. https:\/\/doi.org\/10.1002\/jcsm.12275","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"8549_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, Filiberti A, Fletchner H et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"8549_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/SPC.0000000000000472","volume":"13","author":"JJ McDonald","year":"2019","unstructured":"McDonald JJ, Fallon MT, Laird BJA (2019) Meaningful measures in cancer cachexia: implications for practice and research. Curr Opin Support Palliat Care 13(4):323\u2013327. https:\/\/doi.org\/10.1097\/SPC.0000000000000472","journal-title":"Curr Opin Support Palliat Care"},{"key":"8549_CR13","doi-asserted-by":"publisher","unstructured":"Kadakia KC, Hamilton-Reeves JM, Baracos VE (2023) Current therapeutic targets in cancer cachexia: a pathophysiologic approach. Am Soc Clin Oncol Educ B 43. https:\/\/doi.org\/10.1200\/edbk_389942","DOI":"10.1200\/edbk_389942"},{"key":"8549_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge CD, Fearon KCH (2018) Cancer-associated cachexia. Nat Rev Clin Oncol 4:1\u201318. https:\/\/doi.org\/10.1038\/nrdp.2017.105","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"8549_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI92466","volume":"128","author":"H Roca","year":"2018","unstructured":"Roca H, Jones JD, Purica MC, Weidner S, Koh AJ, Kuo R, Wilkinson JE, Wang Y et al (2018) Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. J Clin Invest 128(1):248\u2013266. https:\/\/doi.org\/10.1172\/JCI92466","journal-title":"J Clin Invest"},{"key":"8549_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cac2.12010","volume":"40","author":"W Zhang","year":"2020","unstructured":"Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Li M, Shuoa S, You Q, Miao L (2020) CXCL5 \/ CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun 40:69\u201380. https:\/\/doi.org\/10.1002\/cac2.12010","journal-title":"Cancer Commun"},{"key":"8549_CR17","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.2147\/OTT.S148772","volume":"10","author":"K Wu","year":"2017","unstructured":"Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K (2017) The clinical significance of CXCL5 in non-small cell lung cancer. Onco Targets Ther 10:5561\u20135573. https:\/\/doi.org\/10.2147\/OTT.S148772","journal-title":"Onco Targets Ther"},{"issue":"1","key":"8549_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0191231","volume":"13","author":"C Th\u00e5lin","year":"2018","unstructured":"Th\u00e5lin C, Lundstrom S, Seignez C, Daleskog M, Lundstrom A, Henriksson P, Helleday T, Phillipson M, Wallen H, Demers M (2018) Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS ONE 13(1):1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0191231","journal-title":"PLoS ONE"},{"issue":"19","key":"8549_CR19","doi-asserted-by":"publisher","first-page":"17511","DOI":"10.1007\/s00432-023-05465-9","volume":"149","author":"M Lipshitz","year":"2023","unstructured":"Lipshitz M, Visser J, Anderson R, Nel DG, Smit T, Steel HC, Rapoport BL (2023) Emerging markers of cancer cachexia and their relationship to sarcopenia. J Cancer Res Clin Oncol 149(19):17511\u201317527. https:\/\/doi.org\/10.1007\/s00432-023-05465-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"8549_CR20","unstructured":"Citrullinated Histone H3 (Clone 11D3) ELISA Kit. no. 501620 (2020) Cayman chemical company, 1180 E Ellsworth Road, Ann Arbor MI, USA. https:\/\/www.caymanchem.com\/product\/501620\/citrullinated-histone-h3-(clone-11d3)-elisa-kit. Accessed 10 Jun 2021"},{"issue":"1","key":"8549_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ijc.1439","volume":"94","author":"K Mystakidou","year":"2001","unstructured":"Mystakidou K, Tsilika E, Parpa E, Kalaidopoulou O, Smyrniotis V, Vlahos L (2001) The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) In terminally ill cancer patients under palliative care: validity and reliability in a hellenic sample. Int J Cancer 94(1):135\u2013139. https:\/\/doi.org\/10.1002\/ijc.1439","journal-title":"Int J Cancer"},{"key":"8549_CR22","unstructured":"Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ- C30 scoring manual.\u00a0 European organisation for research and treatment of cancer,\u00a03rd ed. Brussels, Belgium"},{"key":"8549_CR23","unstructured":"Scott NW, Fayers PM, Aaronson NK, Bottomly A, de Graeff A, Groenvold M, Grundy C, Koller M, Petersen M, Sprangers MA. MAG, EORTC Quality of Life Group (2008) EORTC QLQ- C30 reference values manual. 2nd edn, EORTC Quality of Life Group. Brussels, Belgium. https:\/\/groups.eortc.be\/qol\/downloads\/reference_values_manual2008.pdf. Accessed 26 Jun 2021"},{"issue":"4","key":"8549_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36416\/1806-3756\/e20190420","volume":"46","author":"JP Franceschini","year":"2020","unstructured":"Franceschini JP, Jamnik S, Santoro IL (2020) Role that anorexia and weight loss play in patients with stage iv lung cancer. J Bras Pneumol 46(4):1\u20136. https:\/\/doi.org\/10.36416\/1806-3756\/e20190420","journal-title":"J Bras Pneumol"},{"issue":"45","key":"8549_CR25","doi-asserted-by":"publisher","first-page":"79884","DOI":"10.18632\/oncotarget.20168","volume":"8","author":"M Muscaritoli","year":"2017","unstructured":"Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saraconi V, Barone C, Plastoni F et al (2017) Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget 8(45):79884\u201379896. https:\/\/doi.org\/10.18632\/oncotarget.20168","journal-title":"Oncotarget"},{"issue":"1","key":"8549_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-828","volume":"14","author":"P Mondello","year":"2014","unstructured":"Mondello P, Lacquaniti A, Mondello S, Bolignano D, Pitni V, Aloisi C, Beumi M (2014) Emerging markers of cachexia predict survival in cancer patients. BMC Cancer 14(1):1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-14-828","journal-title":"BMC Cancer"},{"issue":"4","key":"8549_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcsm.12059","volume":"6","author":"CC Ezeoke","year":"2015","unstructured":"Ezeoke CC, Morley JE (2015) Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 6(4):287\u2013302. https:\/\/doi.org\/10.1002\/jcsm.12059","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"8549_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/s1556-0864(15)30411-1","volume":"1","author":"S Sundstr\u00f8m","year":"2006","unstructured":"Sundstr\u00f8m S, Bremnes RM, Brunsvig P, Aaseb\u00f8 U, Kaasa S (2006) Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy? J Thorac Oncol 1(8):816\u2013824. https:\/\/doi.org\/10.1016\/s1556-0864(15)30411-1","journal-title":"J Thorac Oncol"},{"issue":"10","key":"8549_CR29","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.ejca.2006.11.023","volume":"43","author":"LM Pasetto","year":"2007","unstructured":"Pasetto LM, Falci C, Compostella A, Sinigaglia G, Rossi E, Monfardini E (2007) Quality of life in elderly cancer patients. Eur J Cancer 43(10):1508\u20131513. https:\/\/doi.org\/10.1016\/j.ejca.2006.11.023","journal-title":"Eur J Cancer"},{"issue":"1","key":"8549_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","volume":"33","author":"L Martin","year":"2015","unstructured":"Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, Strasser F et al (2015) Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33(1):90\u201399. https:\/\/doi.org\/10.1200\/JCO.2014.56.1894","journal-title":"J Clin Oncol"},{"issue":"1","key":"8549_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcsm.12499","volume":"11","author":"L Daly","year":"2020","unstructured":"Daly L, Dolan R, Power D, Ni Bhuachalla EN, Sim W, Fallon M, Cushen S et al (2020) The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer. J Cachexia Sarcopenia Muscle 11(1):160\u2013168. https:\/\/doi.org\/10.1002\/jcsm.12499","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"8549_CR32","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41430-020-0629-0","volume":"74","author":"AF Bullock","year":"2020","unstructured":"Bullock AF, Greenley SL, McKenzie GAG, Paton LW, Johnson MJ (2020) Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. Eur J Clin Nutr 74(11):1519\u20131535. https:\/\/doi.org\/10.1038\/s41430-020-0629-0","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"8549_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(7):11\u201326. https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.008","journal-title":"Am J Med"},{"issue":"6","key":"8549_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21062040","volume":"21","author":"S Paczek","year":"2020","unstructured":"Paczek S, \u0141ukaszewicz-Zajac M, Gryko M, Mroczko P, Kulczy\u0144ska-Przybik A, Mroczko B (2020) CXCL-8 in preoperative colorectal cancer patients: significance for diagnosis and cancer progression. Int J Mol Sci 21(6):1\u201313. https:\/\/doi.org\/10.3390\/ijms21062040","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8549_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2015.01.010","volume":"73","author":"JB Lim","year":"2015","unstructured":"Lim JB, Chung HW (2015) Serum ENA78\/CXCL5, SDF-1\/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine 73(1):16\u201322. https:\/\/doi.org\/10.1016\/j.cyto.2015.01.010","journal-title":"Cytokine"},{"issue":"10","key":"8549_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s001090000137","volume":"78","author":"G Mantovani","year":"2000","unstructured":"Mantovani G, Maccio A, Mura L, Massa E, Mudu MC, Mulas C, Lusso MR, Madeddu DA (2000) Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 78(10):554\u2013556. https:\/\/doi.org\/10.1007\/s001090000137","journal-title":"J Mol Med"},{"issue":"1","key":"8549_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00520-019-04803-3","volume":"28","author":"ZQ Guo","year":"2019","unstructured":"Guo ZQ, Yu JM, Li W, Fu ZM, Lin Y, Shi YY, Hu W, Ba Y, Li SY et al (2019) Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life. Support Care Cancer 28(1):373\u2013380. https:\/\/doi.org\/10.1007\/s00520-019-04803-3","journal-title":"Support Care Cancer"},{"issue":"2","key":"8549_CR38","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00520-019-04717-0","volume":"28","author":"B Wang","year":"2020","unstructured":"Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G, Yu S (2020) Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer 28(2):581\u2013588. https:\/\/doi.org\/10.1007\/s00520-019-04717-0","journal-title":"Support Care Cancer"},{"issue":"3","key":"8549_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4149\/318_151001N512","volume":"63","author":"O Fiala","year":"2016","unstructured":"Fiala O, Pesek M, Finek J, Racek J, Minarik M, Benesova L, Bortlicek Z et al (2016) Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib. Neoplasma 63(3):471\u2013476. https:\/\/doi.org\/10.4149\/318_151001N512","journal-title":"Neoplasma"},{"issue":"5","key":"8549_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0156008","volume":"11","author":"T Tan","year":"2016","unstructured":"Tan T, Ong WS, Rajasekaran T, Koo KN, Chan LL, Poon D, Chowdury AR, Krishna L, Kanesvaran R (2016) Identification of comprehensive geriatric assessment based risk factors for malnutrition in elderly Asian cancer patients. PLoS ONE 11(5):1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0156008","journal-title":"PLoS ONE"},{"issue":"8","key":"8549_CR41","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/sj.bjc.6600247","volume":"86","author":"M Lind","year":"2002","unstructured":"Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C et al (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86(8):1243\u20131249. https:\/\/doi.org\/10.1038\/sj.bjc.6600247","journal-title":"Br J Cancer"},{"issue":"4","key":"8549_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00520-018-4462-0","volume":"27","author":"M Wu","year":"2019","unstructured":"Wu M, Lian XJ, Jia JM, Cao WT, Yan N, Xin YM, Liu ZR et al (2019) The role of the patient-generated subjective global assessment (PG-SGA) and biochemical markers in predicting anemia patients with cancer. Support Care Cancer 27(4):1443\u20131448. https:\/\/doi.org\/10.1007\/s00520-018-4462-0","journal-title":"Support Care Cancer"},{"issue":"7","key":"8549_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10147-021-01912-0","volume":"26","author":"T Takeda","year":"2021","unstructured":"Takeda T, Sasaki T, Suzumori C, Mie T, Furukawa T, Yamada Y, Kasuga A et al (2021) The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. Int J Clin Oncol 26(7):1293\u20131303. https:\/\/doi.org\/10.1007\/s10147-021-01912-0","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"8549_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1049909119886833","volume":"37","author":"LDAF de Cordeiro","year":"2020","unstructured":"de Cordeiro LDAF, Silva TH, de Oliveira LC, Neto JFN (2020) Systemic inflammation and nutritional status in patients on palliative cancer care: a systematic review of observational studies. Am J Hosp Palliat Med 37(7):565\u2013571. https:\/\/doi.org\/10.1177\/1049909119886833","journal-title":"Am J Hosp Palliat Med"},{"issue":"8","key":"8549_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0161125","volume":"11","author":"EY Kim","year":"2016","unstructured":"Kim EY, Kim YS, Seo J, Park I, Ahn AK (2016) The relationship between sarcopenia and systemic inflammatory response for cancer cachexia in small cell lung cancer. PLoS ONE 11(8):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0161125","journal-title":"PLoS ONE"},{"issue":"9","key":"8549_CR46","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s11136-019-02190-0","volume":"28","author":"L Li","year":"2019","unstructured":"Li L, Chan SL, Mo F, Hui EP, Koh J, Chan AK, Nls Tang, Chu CM, Hui J et al (2019) Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Qual Life Res 28(9):2597\u20132607. https:\/\/doi.org\/10.1007\/s11136-019-02190-0","journal-title":"Qual Life Res"},{"issue":"5","key":"8549_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6084\/m9.figshare.4981502","volume":"12","author":"\u00d8 Paulsen","year":"2017","unstructured":"Paulsen \u00d8, Laird B, Aass N, Lea T, Fayers KS, Klepstad P (2017) The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS ONE 12(5):1\u201316. https:\/\/doi.org\/10.6084\/m9.figshare.4981502","journal-title":"PLoS ONE"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08549-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:07:38Z","timestamp":1718626058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["8549"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08549-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Stellenbosch by the Health Research Ethics Committee (HREC), reference number S19\/10\/223.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"349"}}